A detailed history of Macroview Investment Management LLC transactions in Merus N.V. stock. As of the latest transaction made, Macroview Investment Management LLC holds 114 shares of MRUS stock, worth $4,839. This represents 0.01% of its overall portfolio holdings.

Number of Shares
114
Previous 114 -0.0%
Holding current value
$4,839
Previous $6,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$20.06 - $28.66 $3,751 - $5,359
-187 Reduced 62.13%
114 $3,000
Q3 2023

Oct 26, 2023

SELL
$20.13 - $27.29 $2,455 - $3,329
-122 Reduced 28.84%
301 $7,000
Q2 2023

Jul 13, 2023

BUY
$18.33 - $27.18 $7,753 - $11,497
423 New
423 $11,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.95B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.